The Future of IBS
The Future of IBS
The Future of IBS



Overview
71% of patients were able to better manage their IBS in the first randomised controlled trial (RCT) for Nerva, a hypnotherapy app for IBS. But practitioners were still reaching for low-FODMAP.
So we brought the evidence in front of them. An expert panel turned Nerva's clinical evidence into a conversation practitioners could join.
The campaign stayed close to Nerva's existing identity on purpose. A practitioner might see Nerva at the event, then encounter it again on a referral form months later. The job wasn't to create a new campaign world. It was to make Nerva more memorable within the world it already owned. The only new element was an arrow through the lockup, a visual cue for hypnotherapy moving towards first-line treatment.
Over 1,000 registered, 25% attended, and referrals to Nerva’s hypnotherapy app grew alongside it.
71% of patients were able to better manage their IBS in the first randomised controlled trial (RCT) for Nerva, a hypnotherapy app for IBS. But practitioners were still reaching for low-FODMAP.
So we brought the evidence in front of them. An expert panel turned Nerva's clinical evidence into a conversation practitioners could join.
The campaign stayed close to Nerva's existing identity on purpose. A practitioner might see Nerva at the event, then encounter it again on a referral form months later. The job wasn't to create a new campaign world. It was to make Nerva more memorable within the world it already owned. The only new element was an arrow through the lockup, a visual cue for hypnotherapy moving towards first-line treatment.
Over 1,000 registered, 25% attended, and referrals to Nerva’s hypnotherapy app grew alongside it.
71% of patients were able to better manage their IBS in the first randomised controlled trial (RCT) for Nerva, a hypnotherapy app for IBS. But practitioners were still reaching for low-FODMAP.
So we brought the evidence in front of them. An expert panel turned Nerva's clinical evidence into a conversation practitioners could join.
The campaign stayed close to Nerva's existing identity on purpose. A practitioner might see Nerva at the event, then encounter it again on a referral form months later. The job wasn't to create a new campaign world. It was to make Nerva more memorable within the world it already owned. The only new element was an arrow through the lockup, a visual cue for hypnotherapy moving towards first-line treatment.
Over 1,000 registered, 25% attended, and referrals to Nerva’s hypnotherapy app grew alongside it.
Client
Client
Client
Nerva
Type
Type
Type
B2B
/
Healthcare campaign










